𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

✍ Scribed by Dr. J. Timothy Greenamyre; Robert V. Eller; Zhiming Zhang; Aliza Ovadia; Roger Kurlan; Don M. Gash


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
731 KB
Volume
35
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Neuroprotective effect of riluzole in a
✍ Maria C. Obinu; Michel Reibaud; Véronique Blanchard; Saliha Moussaoui; Assunta I 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

## Abstract Our study aimed to determine whether riluzole, which has shown efficacy as a disease‐modifying agent in amyotrophic lateral sclerosis (ALS), is neuroprotective in a marmoset model of Parkinson's disease (PD). Reduction of energy demand by riluzole could be a rational neuroprotective str

Fipamezole (JP-1730) is a potent α2 adre
✍ Juha-Matti Savola; Michael Hill; Mia Engstrom; Hannele Merivuori; Siegfried Wurs 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian acti

Neuroprotective and restorative effects
✍ Tetsuro Shingo; Isao Date; Hideyuki Yoshida; Takashi Ohmoto 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to possess potent neurotrophic effects on dopaminergic (DA) neurons. We attempted the transplantation of encapsulated GDNF‐producing cells to generate a stable supply of GDNF in the brain to promote neuroprotective and re